Searched for
CRDMO COMPANY INDIA
Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...21 Apr, 2026, 10.20 AM IST- Jefferies' pharma bets are Divi's Laboratories and 3 smallcaps, with up to 30% upside. Here's whyJefferies expects India’s CRDMO sector to see strong growth over 3–5 years, recommending Divi’s Labs, Cohance Lifesciences, Sai Life Scienc...12 Sep, 2025, 05.43 PM IST
- Sai Life Sciences shares drop 4% as TPG Asia likely offloads Rs 2,811 cr worth shares via block dealSai Life Sciences' shares experienced a 4% drop following a significant trade involving 3.2 crore shares. TPG Asia likely divested a 15.4% ...26 Aug, 2025, 09.59 AM IST
- Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendationCohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with ‘Buy’ ratings, citing stro...25 Aug, 2025, 12.16 PM IST
- Avendus Fund, SBI Life lead funding in AragenAvendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in...13 Aug, 2025, 06.00 AM IST
- Anthem Biosciences shares rally 3% after healthy listing. Should you buy now?Anthem Biosciences share price: Anthem’s IPO did not include a fresh issue, with all proceeds going to existing shareholders. Prior to the ...21 Jul, 2025, 11.53 AM IST
- Is Anthem Biosciences IPO a risky bet for investors?Anthem Biosciences, a CRDMO, is set to launch an IPO to raise ₹3,395 crore, diluting the promoter group's stake. While revenue and profit h...14 Jul, 2025, 06.04 AM IST
- Anthem Biosciences IPO: Rs 3,395 crore IPO to open on July 14Anthem Biosciences' Rs 3,395 crore IPO will open on July 14 as a complete Offer for Sale by promoters and investors. The Bengaluru-based CR...08 Jul, 2025, 05.37 PM IST
- India's contract drug makers seek government support in China fightIndia's contract drug makers are seeking government support to remove regulatory hurdles and speed up raw material import clearances. With ...27 Feb, 2025, 12.40 PM IST
- India becoming an attractive option for global pharmaceutical supply chain: Macquarie ReportIndia's CRDMO industry is projected to grow from USD 7 billion to USD 14 billion by 2028, driven by pharmaceutical outsourcing and regulato...20 Feb, 2025, 01.26 PM IST
- Macquarie bullish on Suven Pharma, Divi's Labs, Bluejet and SyngeneMacquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressure...20 Feb, 2025, 05.32 AM IST
- Macquarie initiates coverage on Divi’s Labs, 3 CRDMO firms with up to 40% upside potentialThe global brokerage firm highlights that Indian CDMO companies trade at a 2-year forward EV/EBITDA of 20x, compared to 16x for regional an...19 Feb, 2025, 02.54 PM IST
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True Nort...31 Dec, 2024, 05.54 PM IST
- Anthem Biosciences files DRHP for Rs 3,395 crore IPOAnthem Biosciences has filed its DRHP for an IPO. The issue comprises an offer for sale of up to Rs 3,395 crore by promoters and investors....31 Dec, 2024, 05.43 PM IST
- Sai Life Science grew fast, but pricing looks expensiveThe issue gives a partial exit to private equity investors TPG Asia and HBM. The promoter share will be diluted from 41.8% to 35.2%. The is...11 Dec, 2024, 05.47 AM IST
- India could account for 8-10 pc of work share outsourced to CDMOs by 2033: ReportIndia could take 8-10% of the global outsourcing share for Contract Research Development and Manufacturing Organisations by 2033 due to wor...18 Oct, 2024, 02.40 PM IST
- Want to make India a reliable pharmacy of world, says Secretary Department of PharmaceuticalsThe Indian pharmaceutical industry is emerging as a crucial part of the economy, driven by the success of the Make in India initiative and ...27 Sep, 2024, 01.17 PM IST
Load More
